Why the study?
Does the Ionescu-Shiley pericardial xenograft improve hemodynamic parameters in patients with severe mitral stenosis and/or regurgitation?
Does the Ionescu-Shiley pericardial xenograft improve hemodynamic parameters in patients with severe mitral stenosis and/or regurgitation?
The Ionescu-Shiley pericardial xenograft in the mitral position provides excellent hemodynamic function and marked clinical improvement at 3 to 6 months postoperation.
Answers are grounded in this paper and cite their sources.
May indicate hemodynamic benefit in this case; leaves open confirmation of efficacy and durability in prospective trials.
While the very low thrombogenicity without anticoagulant therapy and generally good durability of the lonescu-Shiley bioprosthesis has been demonstrated, further hemodynamic assessment is necessary. The present study assessed cardiac function and heterograft performance during right and left heart catheterization at rest and exercise (three to six months postoperation) of eight patients with severe mitral stenosis and/or regurgitation prior to surgery. We found, comparing pre- and postoperative resting values, that mean pulmonary artery pressure decreased (32 +/- 2.7 to 22 +/- 3.5 mm Hg; P < 0.02), cardiac index increased (2.1 +/- 0.09 to 2.5 +/- 0.13 liters/min/m2; P < 0.01), pulmonary wedge pressure decreased (21 +/- 2.3 to 13 +/- 1.8 mm Hg; P < 0.01), and the clinical status (NYHA) improved markedly. Mean diastolic gradient across the pericardial xenograft was 6.1 +/- 1.1 mm Hg at rest and 14.6 +/- 2.3 mm Hg on exercise. The calculated xenograft surface area was 1.7 cm2 at rest and 2.0 cm2 during exercise. No regurgitation was detected in seven of eight patients. Thus, mitral lonescu-Shiley bioprosthesis provide excellent heterograft function.
No takes yet. Share an insight, caveat, or question.
Febres-Roman et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: